Encourage the formation of one or more outer matrix components containing a carbon difluorocarboxylic acid derivative. Compounds containing n-octanoil carnosina, plus selected three and / or four peptides, as well as drugs and / or cosmetics containing these ingredients. A method of treating, relieving, and / or improving the existing composition and composition of a symptom, condition, skin condition, or mucusDisease is related to changes in extracellular matrix components. 2. Claim 2: the composition of claim 1, which is characterized by: the lipoamino acid derivative of dioxin, carnosina, is n-octanoil carnosina. 3. Claim 3: the composition of claim 2, which is characterized in that the composition also includes one or more vehicles or former employees suitable for temporary or subcutaneous management. Claim 4: the composition of claim 3, which is characterized in that one or more components of the external matrix are selected from the group consisting of colag I, colag III, colag V and colag VI,collagen VII, collagen XVI, elastin, laminin, hyaluronic acid, fibrillin, heparan proteoglycan sulfate 2, and combinations thereof. Claim 9: The composition of claim 8, characterized in that the composition comprises Octanoyl Carnosine, the lipoamino acid derivative of the GHK tripeptide (N-Palmitoyl-GHK),CISG Article 7Composiciones para estimular la formación de uno o más componentes de matriz extracelular que contienen un derivado lipoaminoácido del dipéptido carnosina. Composiciones que contienen N-Octanoil carnosina en combinación con los tripéptidos y/o tetrapéptidos seleccionados así como también, composiciones farmacéuticas y/o cosméticas que contienen dichas composiciones. Métodos para utilizar las composiciones y composiciones de la presente para tratar, aliviar y/o mejorar un síntoma, condición, trastorno o enfermedad de la piel o mucosa donde el síntoma, condición, trastorno o enfermedad está asociado con cambios en los componentes de la matriz extracelular. Re
